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Abstract
Increased salt consumption is believed to induce high blood pressure  
(BP)-mediated organ damage, although it is not yet clear whether it reflects a 
generalized micro- and macrovascular malfunction independent of BP. Exceeding 
dietary sodium intake is acknowledged to be the main modifiable environmental 
risk factor for cardiovascular events that accounts for an increase in blood pressure 
and induces hypertension (HTN)-related target organ damage. Arterial stiffness is 
well known as an independent cardiovascular risk factor, and sodium intake may be 
a determinant of arterial stiffness. Even so, the studies that investigated the effect 
of dietary sodium reduction intake on arterial stiffness in humans provided incon-
clusive results. Therefore, we aim to perform a review of the available evidence of 
salt restriction and arterial stiffness and its impact on hypertensive patients.
Keywords: salt intake, dietary sodium, arterial stiffness, blood pressure, 
hypertension
1. Introduction
Hypertension (HTN) is a significant risk factor for cardiovascular disease 
(CVD), a major cause of premature death worldwide, and has been identified as one 
of the strongest risk factors in the global burden of disease [1, 2]. Hypertension 
guidelines frequently recommend salt reduction as an important simple strategy to 
reduce high blood pressure (BP) [2–4]. This recommendation is usually extended to 
individuals with normal BP as well as those at risk of becoming hypertensive [5].
The pressure-natriuresis mechanism that was first described by Guyton et al. [6] 
proposes a linkage between dietary sodium intake and renal sodium handling. This 
hypothesis says that, in normal individual, the consumption of high amounts of 
sodium in the diet will cause a transient increase in BP that promotes a higher excre-
tion of sodium by the kidney. The kidney excretes the excess of sodium, leading to 
normal blood pressure restoration. This hypothesis elucidates how blood pressure 
is sustained over the time, although the daily variation in sodium intake is reported 
among most individuals [6–8].
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Excess dietary sodium consumption has several known detrimental effects on 
blood pressure [8–10] and has been associated with a higher risk of stroke and renal 
impairment [11, 12]. Accordingly, there is a strong evidence from randomized con-
trolled trials that a moderate reduction in dietary salt intake safely and effectively 
reduces BP and urinary albumin excretion rate both in hypertensive and diabetic 
patients [13, 14]. Likewise, evidence from epidemiological and clinical studies also 
suggested an association between regular dietary salt intake and pulse wave velocity 
(PWV) [15–17].
This association between dietary salt consumption and pulse wave velocity 
is also supported by experimental evidence in animal models of structural and 
functional changes caused by high salt regimens on the arterial wall above and 
beyond the effect of high BP [18–20]. These changes on arterial wall are believed to 
be induced by both reduced bioavailability of nitric oxide and a deficient response 
of the local renin-angiotensin system to high sodium consumption [21]. Some 
interventional studies in man have investigated the effect of reduction in salt intake 
on arterial stiffness, but their results were not conclusive mainly because of the low 
statistical power of most of them [22–25].
Results from a systematic review and meta-analysis of the available clinical trials 
testing the effect of sodium intake restriction on PWV as a proxy for arterial stiff-
ness, with null hypothesis being that restriction of sodium intake does not affect 
arterial stiffness, indicated that restriction of dietary sodium intake reduces arterial 
stiffness. The authors have suggested that this effect seems to be at least in part 
independent of the changes in blood pressure [26].
To date, the evidence on the effects of dietary sodium restriction on pulse wave 
velocity is still conflicting. Accordingly, this review aims to contribute to increase 
the knowledge about the effects of sodium restriction on arterial stiffness in the 
context of hypertension.
2. Effects of sodium reduction on blood pressure
High sodium intake is linked to a higher risk of stroke, left ventricular hypertro-
phy, and renal impairment and can impair the arterial vasculature and endothelial 
function [10, 22, 27–29]. A moderate reduction in dietary sodium to achieve a 
sodium intake between 1.5 and 2.3 g/day may be cardioprotective independent of 
the BP pathway, but the evidence is not conclusive in this regard. It also may not be 
safe to recommend sodium restriction in older adults with diabetes or those with 
established CVD [3].
Evidence indicates that reducing sodium intake significantly lowers blood 
pressure in both men and women. Sodium is found not only in table of salt but 
also in a variety of foods, including cream, eggs, milk, shellfish, meat, and many 
other processed foods. The World Health Organization (WHO) recommendations 
indicate a reduction in sodium intake to lower blood pressure and risk of stroke, 
cardiovascular disease, and coronary heart disease in adults [30].
The current recommendations in most countries around the world are to reduce 
salt intake from about 9–12 g/day to 5–6 g/day [31]. Much evidence supports that 
such a reduction in salt intake lowers blood pressure. The WHO recommends a 
reduction to <2 g/day sodium (5 g/day salt) in adult individuals [30, 31].
The effects of sodium reduction on blood pressure have been evaluated in 
many studies. In their study that evaluated the effect of sodium reduction on 
blood pressure, D’Elia et al.’s [26] pooled analyses showed a significant reduc-
tion of both systolic blood pressure (SBP) (mean difference, −5.82 mmHg; 
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95% IC, −8.42 to −3.43 mmHg) and diastolic blood pressure (DBP) (mean dif-
ference, −2.75 mmHg; 95% IC, −3.67 to −1.87 mmHg) upon the reduction of 
sodium intake.
Evidence also shows that a modest reduction in salt intake for a couple of weeks 
(4 or more weeks) causes important and significant lowering in blood pressure 
levels in both normal and hypertensive individuals, independent of sex and ethnic-
ity [13]. Salt reduction is linked to a mild increase in noradrenaline, aldosterone, 
and plasma renin activity, and no significant change in lipid concentrations. These 
results may support a reduction in population salt consumption, which would lower 
population mean blood pressure and thereby reduce cardiovascular risk outcomes. 
In their meta-analysis, He et al. [13] have shown that a modest reduction in salt 
intake, as currently recommended, has a significant effect on blood pressure both 
in individuals with hypertension and in those with normal blood pressure. The fall 
in blood pressure is seen in white and black individuals irrespective of their gender. 
These findings provide additional support for reducing salt intake in the population.
3. Effect of sodium intake reduction on pulse wave velocity
Evidences suggest that salt intake plays an important role on blood pressure 
regulation, and it is also suggested a direct effect of salt on large artery wall that 
modulates vascular stiffness [14].
Pulse wave velocity is known to be associated with BP and age [26, 32, 33]. In a 
recent study where the authors have evaluated the effect of salt restriction on pulse 
wave velocity, no significant statistical differences were detected. Although sodium 
restriction reduced SBP and DBP in the combined analysis of all studies, results of 
the meta-regression analysis, however, indicated that the effect of salt restriction on 
arterial stiffness did not depend on changes in blood pressure. In fact, in one of the 
studies included in the meta-analysis, there was a significantly greater reduction in 
pulse wave velocity in black than white and Asian hypertensive patients, despite the 
fact that the three ethnic groups had similar reductions in blood pressure [34].
Another study evaluating the long-term sodium restriction showed an improve-
ment in arterial stiffness independently of the changes in BP [35]. The authors did 
not detect a dose dependence in the pooled association between salt restriction and 
reduction of PWV. Accordingly, the lack of a dose-related effect in the range of 
salt reduction applied in the available studies might be the possible cause of these 
results.
In subgroup analyses of nine cohorts that evaluated the effect of sodium restric-
tion on PWV including prehypertensive and/or hypertensive participants, whereas 
in the five cohorts that enrolled non-hypertensive individuals, an inverse trend 
was detected, but this difference was not statistically significant. A larger effect 
of sodium reduction on PWV was also seen in the three cohorts that included 
hypertensive patients under antihypertensive treatment (5.07%) than in the cohorts 
enrolling untreated normotensive or prehypertensive individuals (1.70%): again, 
however, this difference was not statistically significant [14].
More recently, a study using a hypothetical model to analyze the association 
between salt intake and PWV (carotid-femoral) through direct and mediating 
pathways that aimed to investigate whether the association between salt intake 
and arterial stiffness also has a sex-specific pattern has demonstrated that high salt 
intake has a direct and independent effect increasing on arterial stiffness regard-
less of sex. The authors also concluded that the association between salt intake 
and arterial stiffness is more dependent on BP in normotensive women than it is 
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in normotensive men. As stated by the authors, these results highlight the need 
for a sex-specific approach in the evaluation of cardiovascular risk associated with 
dietary habits [36].
Furthermore, Grigorova et al. [37] have demonstrated that high salt intake was 
associated with an increase in Na/K-ATPase inhibitor marinobufagenin (MBG) 
levels, and an activation of the transforming growth factor-beta (TGF-β) mediated 
pro-fibrotic pathway in the vasculature, leading to an increase of aortic stiffness 
without elevation of BP. MBG activated TGFβ1 pro-fibrotic pathway in cultural 
vascular smooth muscle cell (VSMC), indicating a fundamental role of MBG in the 
development of fibrosis via the Na/K-ATPase signaling function. The decrease in 
salt consumption restored the aortic elasticity through inactivation of the TGF-β 
pathway. Therefore, decreasing salt consumption can improve vascular elasticity 
and lower the risk of cardiovascular disease by MBG level reduction [37].
4. Renal sodium handling, blood pressure, and vascular compliance
The relationship between sodium intake and blood pressure regulation has been 
suggested through animal experiments indicating that a high-sodium diet, at their 
initial phase, leads to volume expansion and cardiac output increases. Based on 
experiments including mainly nephrectomized dogs that received a large amount of 
saline solution daily for 2 weeks, Guyton [7] suggested that the BP increases mainly 
through two mechanisms: (1) volume expansion and cardiac output increases and 
(2) an autoregulatory mechanism that affects the vessel resistance. Accordingly, 
the hypothetic mechanism on how dietary salt increases blood pressure includes 
Guyton’s main theory that the increase in blood pressure is initially associated 
with an increase in extracellular fluid and blood volumes [7, 15, 26]. According to 
Guyton’s hypothesis, in the hypertension pathophysiology, irrespective of the causal 
factor, the pressure-natriuresis relationship in the kidney is always involved, with 
higher blood pressures being required to eliminate a higher given sodium load [38]. 
However, it has never been demonstrated that measurements of extracellular fluid 
volume in hypertensive individuals are modified consistently. All of the authors 
found that the volumes of extracellular fluid and exchangeable sodium were normal 
in hypertensive individuals [39, 40].
The only similitudes were the lower ratio between intravascular and interstitial 
fluid volumes and smaller plasma volume, indicating unbalanced division in hyper-
tensive patients [39]. Additionally, high levels of atrial natriuretic peptide hormone, 
lower levels of plasma renin, and an increased capacity of plasma to inhibit Na+/K+-
ATPase were observed in these patients [15, 41, 42]. In fact, all these apparent 
paradoxes can be easily understood when we observe that, in hypertensive patients, 
if total vascular compliance is reduced, a slight decrease in intravascular volume can 
be too large for the capacity of the corresponding vascular space [39].
Vascular compliance establishes the volume-pressure relationship or the volume 
within a vascular segment and the blood pressure that is generated by the pres-
ence of that blood volume. It is simply the basic concept of compliance applied to a 
vascular segment and represents a classic index of the elasticity of the intravascular 
compartment, from the slope of the curve plotting changes of blood volume (∆V) 
versus changes of intravascular pressure (∆P) [6].
Within a narrow range of volume and pressure changes, the linear relation-
ship curve between both variables is used to define the compliance as the slope 
∆V/∆P [6]. In a clustered circulation model, the vascular compliance expresses 
the sum of complacencies of all vascular segments, including arteries and veins 
[43]. Accordingly, Guyton [6] has defined “total” vascular compliance based on 
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experimental animal models as the relationship between the mean circulatory fill-
ing pressure (MCFP) and blood volume. The MCFP is the pressure that is registered 
throughout the entire circulatory system if the heart is suddenly stopped and the 
blood volume is redistributed entirely in the vascular system taking into account 
the capacity of the vessels. Vascular compliance is then defined as the product 
of volume change and mean circulatory filling pressure. However, as the MCFP 
measurement implies the presence of a non-beating heart, in humans, it cannot 
be measured. Therefore, an alternative index of the capacitance function had to be 
defined.
Evidence from studies in both animals and humans has shown that similar 
indices are observed in cases where the circulation is not interrupted between blood 
volume changes and pressures measured throughout the different parts of the 
venous system [6, 37]. For example, the relationship between rapid blood volume 
expansion (∆V) and central venous pressure (∆CVP) with a plasmatic expander 
such as dextran has the dimensions of compliance [39, 44]. The “true” vascular 
compliance measured from ∆V/∆MCFP ratio is also called “effective” total vascular 
compliance to differentiate it from the ∆V/∆MCFP ratio [39, 45].
Compared to the normotensive patients, the slope of the curve plotting 
blood-volume versus central venous pressure (∆V/∆CVP) is markedly lower in 
hypertensive subjects [39, 45]. On the other hand, there are no changes in curves of 
cardiac output versus blood volume expansion, indicating that the cardiac function 
is maintained despite cardiac structural modifications in hypertensive individuals. 
At these conditions, compared to non-hypertensive individuals, in hypertensive 
patients, the central venous pressure increases more, and the decrease in the effec-
tive compliance of the vascular bed is pointed out as the responsible factor for this 
phenomenon [46, 47].
Evidence suggests that renal sodium handling is the main factor influencing the 
level of intra- and extrarenal blood pressure and is regulated by complex physiolog-
ical and inflammatory mediators, hormones, and the sympathetic nervous system 
[48]. Therefore, a compromised kidney capacity to eliminate sodium in response to 
increased blood pressure is a major factor for a sustained increase in blood pressure, 
irrespective of the primary cause.
The changes registered in plasma sodium levels exert their effects on the vascu-
lar system, affecting not only the small resistance arteries but also the large artery 
properties leading to an increase in arterial stiffness and consequent decrease in 
vascular compliance [49].
Both observational and longitudinal studies have suggested that lower sodium 
intake is associated with lower wave pulse velocity. Evidence suggests that in 
hypertensive patients, a low sodium intake is associated with a larger brachial artery 
diameter than that seen with a high sodium intake [50]. A sodium overload reduces 
arterial distensibility and compliance irrespective of blood pressure changes in 
hypertension in the elderly and in severe hypertension patients with end-stage renal 
disease [51].
5. Sodium-induced change in arterial stiffness and BP
A considerable body of evidence has shown major links along with cause-and-
effect relationships between salt intake and BP [15, 16, 52]. In many studies, both 
SBP and DBP had a similar effect regarding their action on the arterial wall, regard-
less of the presence of a high-sodium diet or not. Remarkably, many observational 




Evidence from studies of genetic models of animal hypertension suggested 
that long-term high sodium intake is associated with increased intima-media 
thickness due to the extracellular matrix (ECM) development and aortic hyper-
trophy regardless of blood pressure. These changes caused by high sodium 
consumption and often associated with increased arterial stiffness and changes in 
smooth vascular cells properties are reversed by reducing sodium and/or giving 
diuretics [16, 53].
Hormonal counterregulatory mechanisms that modulate arterial changes act 
chronically in the presence of a high-sodium diet because bradykinin β2-receptor 
blockage by Hoe-140 (selective B2 bradykinin receptor antagonist that suppresses 
the effects of bradykinin) produces more carotid hypertrophy, while in case of 
normal sodium intake, less aortic collagen accumulates due to AngII-specific type 1 
receptor activity [54, 55].
Several studies have consistently established an independent correlation 
between sodium dietary intake, arterial stiffness, and blood pressure, regardless 
of whether systemic, regional, or local determinations were present [16, 56]. In 
a study addressing the relationship between sodium intake and arterial stiffness 
based on the Chinese populations, Avolio et al. [57] have found that sodium 
intake has an independent effect on arteriolar tone and arterial wall properties, 
with the former indirectly and the later directly contributing to increased arte-
rial stiffness with age. In the same study, the comparison of salt intake between 
urban and rural subjects, as determined by urinary sodium excretion, was greater 
in the urban subjects (13.3 g NaCl/day) than in rural ones (7.3 g NaCl/day). This 
difference was related to higher arterial stiffness and hypertension prevalence 
and lesser vascular compliance in urban subjects. Salt intake had, therefore, an 
independent effect on arterial structural and functional properties, with the 
arterial wall directly and arterial tone indirectly contributing to increased PWV 
with age [16]. Another study from Australia involving young and middle-aged 
(20–66 years old) normotensive subjects on a low-salt diet who were compared 
with age- and BP-matched subjects on a normal-sodium diet showed adult 
subjects on a low-sodium diet have lower arterial stiffness independent of blood 
pressure [35].
On the other hand, the benefits of a low-salt diet on blood pressure seem to be 
greater in hypertensive patients than in normotensive ones. A systematic review 
carried out by Graudal et al. [58] that included 185 randomized controlled tri-
als found that sodium reduction from an average high usual sodium intake level 
(201 mmol/day) to an average level of 66 mmol/day, which is below the recom-
mended upper level of 100 mmol/day (5.8 g salt), resulted in a small decrease 
(1/0 mmHg) in systolic and diastolic BP in white normotensive patients and 
a decrease in systolic and diastolic BP of 5.5/2.9 mmHg in white hypertensive 
patients. The decrease of blood pressure was even greater in black and Asian 
populations.
Moore et al. [59] in their study addressing the effect of low sodium intake on the 
blood pressure levels among Framingham Offspring Study adults even found para-
doxical results. These authors analyzed dietary data from 2632 subjects (normo-
tensive men and women) aged 30–64 years old who were part of the Framingham 
Offspring Study. Over 16 years of follow-up, systolic and diastolic blood pressures 
decreased with increasing sodium intake (≥2.5 g). Mean systolic and diastolic blood 
pressures of 129.5 mmHg and 75.6 mmHg, respectively, were seen among subjects in 
the high-sodium and high-potassium (≥2.3 g) groups compared with 135.4 mmHg 
and 79.0 mmHg, respectively, among people in the low-sodium (<2.5 g) and  
low-potassium (<2.3 g) groups.
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6.  Possible mechanisms of the effect of sodium intake reduction on 
arterial stiffness
Animal studies of hypertension demonstrate that elevated salt consumption can 
increase arterial stiffness and this effect is independent of BP as reviewed by Safar 
et al. [52]. On the other hand, reduced dietary sodium has been shown to lower 
arterial stiffness in humans with hypertension [27, 60]. Cross-sectional studies 
in humans have provided evidence of an independent effect of salt on arterial 
stiffness.
Experimental studies on animal models did show that changes in sodium 
intake have effects on arterial structure and function independent of blood 
pressure [18, 61]. Studies carried out in normotensive rats have shown that these 
changes might be associated with increased production of transforming growth 
factor-beta 1 (TGF-β1), decreased endothelial nitric oxide synthase expression, 
and reduced bioavailability of endothelial nitric oxide induced by a high-salt diet 
[18, 37, 61–63]. TGF-β is a family of three pleiotropic growth factors that have 
complex effects on cell growth and differentiation and organ development, but 
they are particularly important in the expression of extracellular matrix proteins 
and vascular and renal fibrosis promotion in a variety of disease states [64]. The 
TGF-β1 is considered the most important mammalian TGF-β family member syn-
thesized by many cell types including endothelium. It is secreted by endothelium 
acting, basically, on adjacent vascular smooth muscle and seems to be involved in 
blood pressure regulation [37].
The reduction of salt intake in the diet can affect the vascular properties by 
reducing the production of TGF-β. The study by Grigorova et al. [37] has investi-
gated whether high salt intake stimulates the production of MBG, an endogenous 
steroidal Na+/K+-ATPase ligand which activates transforming growth factor-beta 
pro-fibrotic signaling in young normotensive rats and whether these changes can 
be reversed by reducing salt to a normal salt level. Their data have suggested that a 
decrease in salt consumption could help to restore vascular properties such as the 
aortic elasticity and lower the risk of cardiovascular disease by reducing the produc-
tion of the pro-fibrotic factor MBG.
The local renin-angiotensin-aldosterone system (RAAS) is believed to be one 
of the most important mediators of vascular wall elasticity at the heart, vessels, 
and kidneys [19, 65]. At the cardiovascular system, high sodium intake increases 
the AT1 receptor expression and promotes vascular damage [19]. Evidence from 
experimental studies has shown that there was a decrease in aortic collagen accu-
mulation and improvement of vascular, cardiac, and renal function and an AT1 
receptor blocker during the high salt intake diet [12, 19, 66]. Additionally, high 
sodium intake has been reported to increase the vascular angiotensin-converting 
enzyme levels, which opposes to the effects of concomitant renin suppression [67]. 
Studies carried out in hypertensive subjects found gene polymorphisms of aldo-
sterone synthase enzyme and AT1 receptor that was significantly associated with 
higher PWV [68, 69].
Stocker et al. [70] in their study discussing the recent evidence to support the 
role of plasma or cerebrospinal fluid hypernatremia as a key mediator of sym-
pathoexcitation and elevated blood pressure have found that both experimental 
and clinical studies suggested that a high dietary salt increases plasma and cere-
brospinal fluid sodium concentration. Sodium concentration variation modulates 
the sympathetic neurons in rostral medulla by activating the osmoreceptors in the 
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The evidence also point outs the high dietary salt intake is one of the most 
important factors to the activation of the sympathetic nervous system, which is one 
of the main contributing factors for the pathogenesis of salt-sensitive hypertension 
[69, 74]. Although not well understood, it is proposed that increased salt intake 
causes salt retention and raises plasma sodium chloride concentrations, which acti-
vates sodium/osmoreceptors to trigger sympathoexcitation [75]. Some studies have 
suggested that vascular properties such as arterial compliance may be affected by 
sympathetic nervous activity, independently of its effects on BP [76]. Therefore, the 
reduction of salt intake decreases the excitability of the sympathetic nervous system 
and interferes with its effects on vascular properties reducing the arterial stiffness.
7. Conclusions
Health recommendations and most clinical studies have been focused on the 
adverse effects of salt dietary on blood pressure. However, evidence to support 
a deleterious effect of dietary salt on endothelial function and arterial stiffness 
independent of BP is increasing. The mechanisms responsible continue to be 
elucidated. Endothelial dysfunction and increased arterial stiffness are predictors 
of cardiovascular disease, and data from clinical trials have indicated that both are 
associated with incident hypertension. Therefore, reducing excessive salt intake in 
the diet should be considered important for overall vascular health in addition to 
blood pressure control.
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